Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse (Q34188502)

31 July 2017

1 reference

title

Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse (English)

1 reference

31 July 2017

0 references

Weizman A

1

1 reference

PubMed ID

11256582

31 July 2017

Weizman R

series ordinal

2

1 reference

31 July 2017

1 August 2000

1 reference

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

3

1 reference

31 July 2017

335-341

1 reference

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Advances in sodium-ion coupled biogenic amine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

New views of biogenic amine transporter function: implications for neuropsychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Role of the serotonin transporter promoter polymorphism in anxiety-related traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Evidence of linkage between the serotonin transporter and autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Serotonin transporter (5-HTT) gene variants associated with autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

A novel allele in the promoter region of the human serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

How do antidepressants work? Prospects for genetic analysis of drug mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Neurobiology of the Caenorhabditis elegans genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Exploring the metabolic and genetic control of gene expression on a genomic scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Bipolar disorder and the serotonin transporter gene: a family-based association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.1.3.335

21 January 2018

Identifiers

DOI

10.1517/14622416.1.3.335

1 reference

31 July 2017

1 reference

PubMed ID

11256582